Analystreport

aTyr Pharma, Inc. (NASDAQ: LIFE) had its "buy" rating re-affirmed by analysts at Jonestrading. They now have a $15.00 price target on the stock.

Ethos Technologies Inc. - Class A  (LIFE) 
Last ethos technologies inc. - class a earnings: 3/26 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: atyrpharma.com/investors-media